🟢 20/20 Biolabs is trading 5.3% up today as risk-on sentiment lifts small caps

20/20 Biolabs is trading 5.3% up today at $0.45 as investors continue rotating into higher-risk small-cap names amid improving market sentiment.

• The stock appears to be moving in line with a broader risk-on rally as major U.S. indices gain approximately 1%.
• The move extends small-cap strength highlighted in prior sessions, occurring despite a lack of new company-specific news.